CHILDHOOD ACUTE MYELOID LEUKEMIA

Clinical trials for CHILDHOOD ACUTE MYELOID LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new CHILDHOOD ACUTE MYELOID LEUKEMIA trials appear

Sign up with your email to follow new studies for CHILDHOOD ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet recruiting 1

New pill aims to guard against leukemia relapse after transplant

Disease control Recruiting now

This early-stage study is testing a new oral drug called revumenib. It is given to patients who have recently received a stem cell transplant for certain aggressive types of acute leukemia. The goal is to see if taking this drug daily for up to two years is safe and can help keep…

Matched conditions: CHILDHOOD ACUTE MYELOID LEUKEMIA

Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated Apr 03, 2026 14:42 UTC

CHILDHOOD ACUTE MYELOID LEUKEMIA

Get alerted when new CHILDHOOD ACUTE MYELOID LEUKEMIA trials appear

New pill aims to guard against leukemia relapse after transplant